Abstract
The absorption, distribution, metabolism, and excretion of propionylmaridomycin was investigated in the rat by using [14C]propionylmaridomycin. Propionylmaridomycin was absorbed from the gastrointestinal tract at a relatively rapid rate and was readily distributed into tissues. Among the tissues examined, liver, kidney, and lung showed a remarkably higher level of the radioactivity than plasma, while distribution of the radioactivity into brain was little. However, a significant accumulation of the radioactivity in tissues was not observed. Excretion of the radioactivity was mainly via the fecal route and the high fecal recovery was accounted for by unabsorbed drug and biliary excretion of the drug and/or its metabolites. Tissue distribution of antimicrobial activity was also investigated and lung was found to show the highest antimicrobial activity among any tissues examined. Propionylmaridomycin was completely converted to several metabolites by the rat and the presence of at least three components was confirmed as biologically active metabolites. Of these metabolites, 4″-depropionyl-9-propionylmaridomycin was identified, which was the major metabolite in tissues, plasma, and urine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Harada S., Muroi M., Kondo M., Tsuchiya K., Matsuzawa T. Chemical modification of maridomycin, a new macrolide antibiotic. Antimicrob Agents Chemother. 1973 Aug;4(2):140–148. doi: 10.1128/aac.4.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kondo M., Ishifuji K., Tsuchiya K., Goto S., Kuwahara S. Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin. Antimicrob Agents Chemother. 1973 Aug;4(2):156–159. doi: 10.1128/aac.4.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kondo M., Oishi T., Tsuchiya K., Goto S., Kuwahara S. Maridomycin, a new macrolide antibiotic. In vitro antibacterial activity of 9-propionylmaridomycin. Antimicrob Agents Chemother. 1973 Aug;4(2):149–155. doi: 10.1128/aac.4.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuriaki K., Sado T., Sano K., Sasaki H., Shiobara Y. [New antibiotics, Josamycin. VI. Study on absorption and distribution of Josamycin]. Jpn J Antibiot. 1969 Jun;22(3):226–231. [PubMed] [Google Scholar]
- Muroi M., Izawa M., Kishi T. Maridomycin, a new macrolide antibiotic. 8. Isolation and structures of metabolites of 9-propionylmaridomycin. J Antibiot (Tokyo) 1974 Jun;27(6):449–459. doi: 10.7164/antibiotics.27.449. [DOI] [PubMed] [Google Scholar]
- Ono H., Harada S., Kishi T. Maridomycin, a new macrolide antibiotic. VII. Incorporation of labeled precursors into maridomycin and preparation of 14C-labeled 9-propionylmaridomycin. J Antibiot (Tokyo) 1974 Jun;27(6):442–448. [PubMed] [Google Scholar]
- Potter J. L., Matthews L. W., Spector S., Lemm J. Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions. Pediatrics. 1965 Nov;36(5):714–720. [PubMed] [Google Scholar]
- Stephens V. C., Pugh C. T., Davis N. E., Hoehn M. M., Ralston S. A study of the behavior of propionyl erythromycin in blood by a new chromatographic method. J Antibiot (Tokyo) 1969 Nov;22(11):551–557. doi: 10.7164/antibiotics.22.551. [DOI] [PubMed] [Google Scholar]